Age-Related Macular Degeneration Market Epidemiology Report 2025-2035: Drugs Pipeline, Therapies, and Forecast The report provides a detail ...

Paris: Sanofi has received fast track designation from the US Food and Drug Administration (FDA) for SAR446597, a one-time ...

Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration Designation earned for a one-time intravitreal gene therapy designed to inhibit ...

Canadian study reveals diabetic patients taking GLP-1 medications face twice the risk of eye problems, with longer exposure increasing danger of macular degeneration.

Singapore researchers have discovered that a new cancer drug, originally developed at A*STAR Institute of Molecular and Cell ...

Fact checked by Jennifer Klump GLP-1 drugs may increase the risk of a severe form of macular degeneration in older adults with diabetes, according to a recent study published in JAMA Ophthalmology. A ...

This discovery could make treatment for an eye disease affecting millions with diabetes more accessible and affordable.

Whether you’re a latte lover, a mocha monster or an espresso elitist — people have strong preferences when it comes to coffee ...

Scientists have discovered that a locally developed cancer drug, PRL3-zumab, may offer a groundbreaking treatment for two ...

GLP-1 drugs like Ozempic are associated with a higher risk of developing wet age-related macular degeneration in people with type 2 diabetes, according to a new study. The risk increased the ...

Age-related macular degeneration (AMD) can lead to feelings of anxiety and depression. Here’s what to watch for and how to safeguard your mental health.

Alcon has inked a deal to acquire LumiThera and its light-based therapy for dry age-related macular degeneration, which ...